Deans' stroke musings: SyncThink gets FDA approval for eye-tracking device to test for concussions in 60 seconds

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, April 26, 2016

SyncThink gets FDA approval for eye-tracking device to test for concussions in 60 seconds

Why not be able to use this for stroke also? At least we wouldn't have emergency room doctors accusing young stroke patients of being drunk or drugged and spending hours with millions of neurons dying until they are treated.

SyncThink gets FDA approval for eye-tracking device to test for concussions in 60 seconds

SyncThink, a company that has led the field of eye tracking technology, has announced that it has received FDA clearance for its medical device, EYE-SYNC, which uses infrared cameras to determine within 60 seconds if someone has endured a concussion.
Concern about concussions is clearly a very public issue now for athletes. By measuring visual target motion, this handheld, virtual reality, eye-tracking technology can determine whether an athlete has been concussed. It’s often faster than a medical examiner, the company said.
SyncThink, which has headquarters and research staff in Boston, New York and Palo Alto, collaborated with the Brain Trauma Foundation in developing this device.
“In my opinion, the EYE-SYNC device has significant implications for sideline evaluation, and I can see in the future how this can be the diagnostic gold standard for sports related concussion with every pro, college and high school team having one on the field,” Scott Anderson, director of athletic training for Stanford University Sports Medicine, said in a SyncThink statement.
Anderson said that Stanford Sports Medicine is testing EYE-SYNC as an investigational device to screen athletes for concussions and help decide if it is safe for them to return to play.
SyncThink claims more than 40 peer-reviewed research articles demonstrating the effectiveness of the device, plus 10 patents and a database of more than 10,000 people who have been tested with EYE-SYNC.